NEW YORK (360Dx) – A team led by researchers from France’s Sys2diag laboratory have developed synthetic biology-based biosensors capable of detecting biomarkers in human clinical samples.

The sensors consist of synthetic protein signaling networks encased in phospholipid bilayer membranes. In a proof-of-concept study published last month in Molecular Systems Biology, the networks were able to detect diabetes-linked markers in patient urine samples.